Morepen Laboratories Ltd. (MOREPENLAB)
Market Closed
10 Aug, 22:00
MSE XNSE Primary MSE ₹
79. 25
-0.87
-1.0859%
₹
- Market Cap
- P/E Ratio
2.4% Div Yield
602,113 Volume
- Eps
₹ 80.12
Previous Close Want to track MOREPENLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
MOREPENLAB closed today lower at ₹79.25, a decrease of -1.0859% from yesterday's close, completing a monthly increase of 32.1054% or ₹19.26. Over the past 12 months, MOREPENLAB stock gained 95.679%.
MOREPENLAB pays dividends to its shareholders, with the most recent payment made on Oct 06, 2025. The next announced payment will be in In 1 month on Sep 18, 2026 for a total of ₹0.2.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.416%, based on the last three reports.
Morepen Laboratories Ltd. has completed 1 stock splits, with the recent split occurring on Nov 07, 2000.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
MOREPENLAB Chart
Morepen Laboratories Ltd. (MOREPENLAB) FAQ
What is the stock price today?
The current price is ₹79.25.
On which exchange is it traded?
Morepen Laboratories Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is MOREPENLAB.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.4%.
What is its market cap?
As of today, no market cap data is available.
Has Morepen Laboratories Ltd. ever had a stock split?
Morepen Laboratories Ltd. had 1 splits and the recent split was on Nov 07, 2000.
Morepen Laboratories Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | MSE Exchange | INE083A01026 ISIN |
| India Country | 2,152 Employees | 18 Sep 2026 Last Dividend | 7 Nov 2000 Last Split | - IPO Date |
Overview
Morepen Laboratories Limited is a prominent entity in the pharmaceutical sector that focuses on the development, manufacturing, marketing, and sales of active pharmaceutical ingredients (APIs), formulations, and home health products. Established in 1984 and headquartered in Gurugram, India, the company has a wide-reaching presence, catering to markets in India, the United States, and across the globe. Morepen Laboratories has carved out a niche for itself by offering a broad range of medical solutions, spanning from essential drugs to home diagnostic kits, under the renowned Dr. Morepen brand.
Products and Services
The company’s expansive portfolio is segmented into several critical healthcare and medicinal categories, including:
- Active Pharmaceutical Ingredients (APIs): Morepen produces APIs for a vast array of therapeutic areas such as anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs. These ingredients form the backbone of many essential medications, highlighting the company's integral role in the global healthcare chain.
- Home Diagnostic Products: The range includes air purifiers, sphygmomanometers (blood pressure monitors), blood glucose test strips, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. Each product is designed to facilitate easy and accurate health monitoring from the comfort of the home, thereby promoting preventive healthcare practices.
- Over The Counter (OTC) Products: Marketed under the Dr. Morepen brand, these products are readily accessible without a prescription and cater to everyday health needs. The lineup includes Fever X for fever, Pain X for pain, Fiber-X as a dietary fiber source, Acidity X for acidity relief, and Burnol cream for first-degree or minor burns. Morepen also offers formulations for nutrition and probiotics, addressing gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system treatments, along with cardiology, diabetology, and nutraceuticals. This extensive OTC range highlights Morepen’s commitment to addressing a wide spectrum of consumer health concerns.
Contact Information
Address: Tower C, DLF Cyber Park
Phone: 91 12 4489 2000
Website: https://www.morepen.com
